INVO Fertility Reports Third Quarter 2026 Results Highlighting 28% Clinic Revenue Growth and Continued Positive Clinic-Level Adjusted EBITDA
Record quarterly clinic revenues supported by both organic growth and acquisitionsSeventh consecutive quarter of positive Clinic-Level Adjusted EBITDABalance sheet continues to improve following debt repaymentsSARASOTA, Fla., Nov. 16, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. NASDAQ:IVF (“INVO…